New drug aims to save sight in rare genetic disorder
NCT ID NCT07290530
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tests whether an experimental drug called NPI-001 can slow the loss of light-sensing cells in the eyes of people with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 adults will take either the drug or a placebo twice daily for two years. Researchers will measure changes in the area of healthy retina to see if the treatment preserves vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA (RP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.